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Primeiro escore de risco inflamatório das endopróteses de aorta
First inflammatory risk score for aortic
endoprostheses
Abstract
Objective: To propose an inflammatory risk score for
aortic aneurysm endovascular treatment.
Methods: Twenty-five patients were followed-up from the
preoperative period to the third postoperative month (1 hour,
6 hours, 24 hours, 48 hours, 7 days, 1 month, 2 months and 3
months). Inflammatory variables were C-reactive protein,
the blood sedimentation velocity, interleukins (IL-6, IL-8),
tumor necrosis factor-Alpha, L-selectin, intercellular
adhesion molecule (ICAM-1), red blood cell transfusion,
volume of crystalloid solution, volume of contrast, type of
endoprosthesis, number of endoprostheses and total
leukocyte and lymphocyte counts. Spearman test defined
the variables considered candidates for higher inflammatory
risk based on a P < 20%. Logistic regression defined the
variables considered in the selection of the final score based
on a P <  10%. ROC curve analysis revealed the cut-off
values for variables selected by logistic regression.
Results: Variables defined by the Spearman test were:
volume of crystalloid (P=0.04), type of endoprosthesis
(P=0.04), volume of contrast (P=0.02), preoperative IL-8 (P =
0.10), 1-month ICAM-1 (P=0.03) and 1-month L-selectin
(P=0.06). Logistic regression revealed that the volume of
crystalloid and preoperative IL-8 are relevant in the
composition of the inflammatory risk score for aortic
aneurysm endovascular treatment. The risk score would be
divided into three categories (mild, moderate and severe)
based on numeric intervals of these two variables with the
categories being correlated to clinical findings.
Conclusion: Volume of crystalloid and preoperative IL-8
are variables that might contribute to categorize
inflammatory risk and thus they might play a prognostic
role in aortic aneurysm endovascular treatment.
Descriptors: Prostheses and implants. Inflammation.
Aorta/surgery. Risk. Risk assessment.
Resumo
Objetivo: Propor um escore de risco inflamatório para
tratamento endovascular dos aneurismas da aorta.
Métodos: Vinte e cinco pacientes foram seguidos do
período pré-operatório até 3º mês de pós-operatório (1 hora,
6 horas, 24 horas, 48 horas, 7 dias, 1 mês, 2 meses e 3 meses).
Variáveis inflamatórias avaliadas foram proteína C reativa,
velocidade de hemossedimentação, interleucinas (IL-6, IL-
8), fator de necrose tumoral alfa, L-selectina, molécula de
adesão intercelular (ICAM-1), transfusão de hemáceas,
volume de cristalóide, volume de contraste, material da
prótese, número de próteses, contagem total de leucócitos e
linfócitos. O teste de Spearman apontou as variáveis
candidatas ao maior risco inflamatório, segundo P < 20%. A
regressão logística apontou variáveis selecionáveis para
escore final segundo P < 10%. A análise da curva ROC revelou
valores de corte para variáveis selecionadas pela regressão
logística.
Resultados: Variáveis apresentadas pelo teste de Spearman
foram: volume de cristalóide (P = 0,04), material da prótese (P
= 0,04), volume de contraste (P=0,02), IL-8 pré-operatória (P=
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INTRODUCTION
The prognosis and life expectancy of individuals with
aortic aneurisms depends on several factors, including the
time of diagnosis, the adequate choice of therapeutic
modality, as well as the postoperative radiological follow up.
For many years, the most indicated surgical treatment
for aortic aneurisms was the substitution of the dilated
segment using a prosthetic material, with or without the re-
implantation of related arterial branches [1].
In 1991, the success obtained by Parodi et al. in the
correction of an abdominal aortic aneurism using an
endoprosthesis, gave vascular and cardiovascular
surgeons another option of a novel and promising therapy,
in particular for individuals with numerous or considerably
deleterious comorbidities [2]. Despite of the satisfactory
results obtained with the endovascular treatment of aortic
aneurisms, some complications have been documented,
such as the occurrence of strokes, paraplegia, prosthetic
migration, embolic phenomenon and leaks [3-6].
Gabriel et al. [7] recently demonstrated that the
endovascular procedure for the correction of aortic
aneurisms involves factors related to a systemic
inflammatory response, both in the acute phase and in a
later phase of the postoperative follow up. These authors
postulated that inflammatory mediators, such as cytokines
and cellular adhesion molecules, can be better evaluated
by means of curves that register the variability of their
serum levels over time. This knowledge is of notable
relevance for the professional that performs the
endovascular procedure, largely because it enables the
correlation of different postoperative clinical manifestations
with the inflammatory role that each marker may play in the
organism. Moreover, by knowing and understanding this
correlation, it will be possible, if necessary, to institute an
effective medicinal treatment.
However, there are no studies that define which
inflammatory variables are elementary to the prognosis of
individuals submitted to the endovascular treatment of
aortic aneurisms [7].
Hence, the aim of this study is to propose an
inflammatory risk score for individuals submitted to the
endovascular correction of aortic aneurisms.
METHODS
This research was approved by the Research Ethics
Committee of the Federal University of Sao Paulo
(UNIFESP) and complies with the Declaration of Helsinki.
All the individuals signed written consent forms before
participating in the study.
In the period from March to December 2005, 25 patients
with thoracic or abdominal aortic aneurisms were
prospectively enrolled. The exclusion criteria were acute
dissections, traumatic dissections, inflammatory aneurisms,
conjunctive tissue diseases and patients presenting with
any sign of infection or immunodeficiency at the time of the
endovascular procedure. The demographic characteristics
and operative aspects are shown in Table 1. Some
inflammatory variables considered in this study were
evaluated in the preoperative period (24 hours before the
endovascular procedure) and at several intervals during the
postoperative follow up (1 hour, 6 hours, 24 hours, 48 hours,
7 days, 1 month, 2 months and 3 months). All these variables
were considered parametric except for intramural thrombi and
material of the endoprosthesis, which were analyzed as non-
parametric. The parametric variables were employed to obtain
a risk score model, considering only the time at which they
were most prevalent (Table 2), based on the study performed
by Gabriel et al. [7]. The hypothesis was, that the higher the
values of the parametric variables, the greater the risk of
inflammation; on the other hand, the simple presence of non-
parametric variables would be compatible with a greater
probability of risk. The raw data of 25 patients in relation to
the variables and intervals of time of greatest prevalence, as
demonstrated in Tables 3 and 4, allows us to apply a step-
by-step method to configure a risk score.
Initially, the Spearman test determined which
inflammatory variables can be classified as candidates for
the score model based on a level of significance d” 20%
0,10), ICAM-1 1 mês (P=0,03) e L-selectina 1 mês (P = 0,06). A
regressão logística revelou que os valores do volume de
cristalóide e IL-8 pré-operatória são primordiais para
constituição do escore de risco inflamatório para tratamento
endovascular dos aneurismas da aorta. O escore de risco seria
dividido em três categorias (leve, moderado e grave), com
base em intervalos numéricos das duas variáveis selecionadas
e as categorias seriam correlacionadas com achados clínicos.
Conclusão:  Volume de cristalóide e  IL-8 pré-
operatória são variáveis que poderiam contribuir para
categorizar risco inflamatório e, desse modo, ter um
papel prognóstico no tratamento endovascular dos
aneurismas da aorta.
Descritores: Próteses e implantes. Inflamação. Aorta/
cirurgia. Risco. Medição de risco.
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Table 1. Demographic and operative aspects
Variable
 
Gender
Men
Women
 
Comorbidities
Hypertension
Diabetes mellitus - ID
Diabetes mellitus - NID
Obesity
Smoking
COPD
Previous strokes
Previous acute myocardial infarction
instable angina
stable angina
congestive heart failure
chronic renal failure *
Dyslipidemia
liver failure
atrial fibrillation
other arrhythmias
peripheral vascular disease
Gout
 
Volume of crystalloid solution
< 2000 mL
2000 - 3000 mL
> 3000 mL
Transfusion of red blood cells
Yes
 No
 
Volume of contrast
40 - 160 mL
160 - 280 mL
Material of the endoprosthesis
Stainless steel
Nitinol
Stainless steel + nitinol
 
Number of endoprostheses
1 - 3
4 - 5
 
Thrombi
Yes
No
N
 
 
21
4
 
 
25
0
2
8
18
6
1
5
1
2
1
2
8
0
0
4
0
2
 
 
13
7
5
 
6
19
 
 
20
5
 
 
22
2
1
 
 
23
2
 
 
17
8
%
 
 
84
16
 
 
100
0
8
32
72
24
4
20
4
8
4
8
32
0
0
16
0
8
 
 
52
28
20
 
24
76
 
 
80
20
 
 
88
8
4
 
 
92
8
 
 
68
32
ID: Insulin-dependent; NID: non-insulin-dependent; DPOC:
Chronic occlusive pulmonary disease; * (serum creatinine >
2mg/dL)
Table 2. Inflammatory variables and period of greatest prevalence
Variable Time
total neutrophil count 24 hours
total lymphocyte count 1 month
Volume de crystalloid solution – mL *
Volume de contrast - mL *
Transfusion of red blood cells *
Presence of intraluminal thrombi **
Material of endoprosthesis **
Number of endoprostheses *
Velocity of blood sedimentation - mm/h 7 days
C-reactive protein (CRP) - mm/dL 48 hours
Interleukin 6 (IL-6) - pg/mL 24 hours
Interleukin 8 (IL-8) - pg/mL pre-operative
tumoral necrosis factor alpha (TNF-á)-pg/mL pre-operative
intercellular adhesion Molecule (ICAM-1)-pg/mL 1 month
L-selectin - pg/mL 1 month
* parametric variables related to the intra-operative period;
** non-parametric variables
(Table 5). Subsequently, logistic regression was applied to
select variables that effectively would be used in the
establishment of an inflammatory risk score. In this final
selection phase, a level of significance < 10% was adopted.
Analysis of the ROC curve was utilized to determine cut-
off values for the variables identified by the logistic
regression test.
RESULTS
The logistic regression test identified the volume of
crystalloid solution and the preoperative level of IL-8 as
possible variables for the formation of an inflammatory risk
score. The analysis of the ROC curve (Figure 1) indicated
that the highest values of sensitivity and specificity found
for the volume of crystalloid solution and the preoperative
IL-8 level were 1850 mL and 33.53 pg/mL, respectively and,
thus, these should be the cut-off values for the variables.
Hence, it was possible to allocate the values of both
variables, found for the 25 patients, to different categories
of inflammatory risk, as well as to estimate the maximum
probability of risk (Table 6). Table 7 demonstrates the model
of inflammatory risk score of aortic endoprostheses based
on the correlation of the cut-off values and different numeric
intervals with the most common clinical manifestations.
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Table 3. Raw dada of the 25 patients (part I)
Pacient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Thrombus
Yes
Yes
Yes
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Tr
No
No
Yes
Yes
No
Yes
No
Yes
No
Yes
No
No
No
Yes
No
No
No
No
No
No
No
No
No
No
No
VC
3000
3500
1200
1750
2000
2000
2000
3500
1500
3500
1500
1250
2500
4000
2500
1500
2500
2500
3000
1500
3000
3500
1500
1500
1000
ME
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1 e 2
1
2
1
1
1
NE
3
3
3
1
3
3
3
4
3
3
2
3
3
5
2
3
3
3
2
3
3
2
3
3
2
VCON
50
58
80
170
140
160
120
140
120
200
40
90
105
188
100
120
60
180
280
130
150
120
110
110
110
VHS 7d
45
51
9
51
23
39
62
0
51
120
78
57
36
7
18
25
35
51
9
5
67
96
25
0
112
PCR 48h
9.42
13.00
40.50
32.80
4.13
9.20
15.80
21.70
8.66
19.25
6.11
14.30
26.00
19.50
23.00
21.20
22.30
11.40
15.00
15.00
15.00
15.00
9.73
30.40
14.21
IL6 24h
105.85
74.02
211.75
121.04
75.47
44.19
0.00
981.70
49.02
155.54
2.54
18.68
125.43
768.70
59.51
768.70
218.84
89.40
24.15
2000.00
39.54
1500.00
17.37
259.70
325.42
pre IL8
28.36
106.07
646.98
59.34
11.05
15.11
2.15
51.85
6.47
45.37
15.11
0.00
15.11
1802.09
2.15
230.03
13.63
221.82
59.80
23.40
54.89
38.70
0.00
21.59
25.63
Tr –Red blood cell  transfusion; VC - volume de crystalloid solution;  ME - material of the endoprosthesis ; NE - number of endoprostheses;
VCON - volume of contrast
Table 4. Raw dada of the 25 patients (part II)
Pacient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
ICAM1m
895.01
879.95
810.91
719.56
2120.00
2100.00
4.75
855.98
785.44
664.18
806.05
59.70
1274.81
519.93
1613.10
1200.00
739.40
1836.74
2.20
1836.74
1850.00
1872.55
11.70
416.89
405.40
Lsel 1m
2130.02
3030.18
1512.48
2479.06
3466.66
2655.86
0.00
27.60
15.23
9.35
9.65
3.00
1619.29
16.44
3948.30
3948.30
2508.91
5000.00
1575.40
3265.13
3566.59
3566.59
987.70
12.82
1306.70
pre TNF
98.21
18.21
168.20
26.43
6.37
12.86
6.09
16.81
8.12
18.12
11.51
12.18
14.19
31.74
24.02
20.09
33.74
0.00
4589.00
2588.70
1568.40
3217.40
19.43
6.77
40.09
Leuk 24h
7500
13000
14600
13600
12600
8700
20500
21400
9200
14600
11900
9000
16900
16800
8900
9000
14500
10600
10900
9800
6500
12900
5000
17000
12000
Ly 1m
1600
1100
2800
1600
2700
2400
2600
938
1900
1700
1400
1200
2000
800
1500
1700
2000
2400
2200
1800
1700
3400
1200
2600
1800
ICAM  -  intercellular adhesion molecule; Lsel - L-selectin; TNF -
tumoral necrosis factor; Leuk - total leukocyte count; Ly - total
lymphocyte count
Table 5. Candidate variables for the risk score model
Variable
Volume de crystalloid solution
Material of endoprosthesis
Volume of contrast
pre-operative IL-8
ICAM-1  1 month
L-selectin 1 month
Level of significance (P)*
0.04
0.04
0.02
0.10
0.03
0.06
* Spearman Test - P< 20%.
ICAM  -  intercellular adhesion molecule
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DISCUSSION
The treatment of aortic aneurisms by open surgery with
the associated complications results, in some
circumstances, in a high risk of morbidity and mortality.
Added to this is the fact that repair of this disease by the
conventional approach requires, in most cases, the use of
cardiopulmonary bypasses, which confers a greater risk of
postoperative complications.
The viability and efficacy of endovascular therapy in
the correction of aortic aneurisms have been consolidated
due to the possibility of performing less invasive
procedures, in particular when there are associated risk
factors, such as age, chronic obstructive pulmonary
disease, hypertension, smoking, chronic renal failure and
cardiovascular diseases [8-10].
The complex reactions resulting from the interaction
between the aortic endothelium and the endoprosthesis
can be conceptualized as post-implantation syndrome,
which is characterized by the expression of multiple and,
often, lethal organic effects. Some subjacent events are
being studied in order to clarify the main mechanisms that
cause this syndrome. Extensive endothelial activation after
the implantation of an endoprosthesis, activation due to
the contact of blood components with the surface of the
endoprosthesis, as well as ischemia-reperfusion lesions
owing to prolonged periods of clamping of the femoral
arteries, have been considered possible etiologies of this
process. Additionally, from the physiopathological point
of view, some clinical manifestations may be correlated to
these events including leukocytosis, fever and coagulation
disorders.
An estimation of inflammatory risk in the endovascular
treatment of aortic aneurisms is still not possible due to the
inexistence of a specific score that encompasses the
inflammatory variables inherent to this type of therapy. In
this study, the follow up of 25 patients submitted to the
endovascular treatment demonstrates that there are several
Fig. 1 - A: Analysis of the ROC curve for the volume of crystalloid
solution; B: Analysis of the ROC curve for the pre-operative values
of IL-8
Table 6. Numeric intervals and risk categories
Volume de crystalloid
solution (mL)
Up to 1850
1850 - 3250
> 3250
3500
IL-8 pre
(pg/mL)
Up to 33.53
33.54 – 53.37
> 53.37
38.7
Risk
Mild
Moderate
Severe
Severe
Probability
Up to 70%
71% - 82%
> 82%
86.59% *
* maximum probability of risk
Table 7. Inflammatory risk score
Volume of crystalloid
solution (mL)
Up to 1850
1850 - 3250
> 3250
IL-8 pre
(pg/mL)
Up to 33.53
33.54 – 53.37
> 53.37
Risk
Mild
Moderate
Severe
Clinical
manifestations
Fever/
Leukocytosis
Fever/
Leukocytosis/
Hypotension
SIRS*/Sepsis
* SIRS - Systemic Inflammatory Response Syndrome
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inflammatory variables involved in the systemic
inflammatory response induced by contact of the
endothelium with the endoprostheses; however, the
volume of crystalloid solution and the preoperative value
of IL-8, in particular, were identified as probable variables
to be included in the creation of an original model of an
inflammatory risk score.
Several mechanisms are involved in the inflammatory
response induced by the infusion of crystalloid solution. A
number of authors have postulated that, the more
crystalloid solution utilized, the greater the transcription of
pro-inflammatory genes, the greater the expression of
cellular adhesion molecules, such as E-selectin and P-
selectin, the greater the neutrophil activation and the
greater the release of cytokines and hydrogenated
metabolites will be [11-15]. Pascual et al. [16,17]
demonstrated that the infusion of hypertonic solutions
might reduce the adhesion and transmigration of
inflammatory cells.
The majority of aortic aneurisms are primarily associated
with the atherosclerotic process and, secondly, correlated
with transmural degenerative processes,
neovascularization, reduction in the quantity of smooth
muscle cells and chronic inflammatory infiltration, The
dominant cells of this infiltration are T helper 2 lymphocytes,
that participate in the synthesis of inflammatory mediators
such as IL-8 and TNF-á. Lindeman et al. [18] removed
fragments of the aneurismal walls from the human aorta
and demonstrated that, in this type of tissue, there is
increased expression and activation of interleukins, in
particular IL-6 and IL-8. These findings are compatible with
the relevance of preoperative values of IL-8 identified in
the current study, which is fundamental to an adequate
estimation of inflammatory risk of aortic endoprostheses
[18-21].
Although the inflammatory risk score for aortic
endoprostheses is useful in obtaining better postoperative
results, its applicability should not discard the impact on
the cost of the procedure and, thus, attention should be
paid to this question.
CONCLUSION
The authors of the current study propose a model of an
inflammatory risk score for the endovascular treatment of
aortic aneurisms, in an attempt to determine which
inflammatory factors effectively might have a reasonable
impact in prognostic terms. In the first analysis, the volume
of crystalloid solution utilized in the endovascular
procedure and the pre-operative value of IL-8 have been
indicated for this evaluation. Nevertheless, this
investigation must be amplified with further studies to
optimize the results.
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